AzTrials
AzTrials

Hemorrhagic ShockNCT04987411

Detection of Exhaled Methane Levels in Hemorrhagic Shock

An observational study of Hemorrhagic Shock and Trauma, run by Szeged University at 1 site in Hungary.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This prospective observational study aims to test the efficacy of the continuous measurement of exhaled methane levels in monitoring the hemodynamic state of severely injured, bleeding trauma patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hemorrhagic Shock, Trauma
What is being tested?
Measurement of methane concentrations in exhaled breath, Videomicroscopy of the sublingual microcirculation and Blood gas and laboratory analysis
How many people
40 participants
Where
1 siteHungary
Study dates
1 Nov 2021to 31 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Severely injured (ISS)≥16, intubated trauma patients with active bleeding.

Who may be able to join

  • injury severity score (ISS)≥16
  • intubated on scene or upon arrival
  • transported directly from scene to the Emergency Department of the University of Szeged
  • hemorrhage confirmed with eFAST or CT
  • consent signed by patient surrogate

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Péter Dr. Jávor, M.D. contact

+36703193420

peter.javor.md.@gmail.com

Hungary1 site
  • Department of Traumatology, University of Szeged

    Szeged, 6720

    Eszter Bucsuház, +3662545531, office.trauma@med.u-szeged.hu

    Petra Dr. Hartmann, MD, Ph.D.

Other trials in Hungary

About this study

Official title: Detection of Exhaled Methane Levels for the Recognition and Monitoring of Hemorrhagic Shock - Study Protocol for a Prospective Observational Study

This prospective observational study aims to test the efficacy of the continuous measurement of exhaled methane levels in monitoring the hemodynamic state of severely injured, bleeding trauma patients.

Read the detailed description

This prospective observational study aims to test the efficacy of the continuous measurement of exhaled methane levels in monitoring the hemodynamic state of severely injured, bleeding trauma patients. Our inclusion criteria require an age of 18 years or greater, an Injury Severity Score (ISS) of 16 or greater, transport directly from scene, intubation on scene or upon arrival, hemorrhage confirmed with eFAST or CT, and signed consent from patient surrogates. Exhaled methane concentrations and indicators of blood loss and shock (vital signs: systolic blood pressure, heart rate; blood gas and laboratory markers: base deficit, lactate, hemoglobin, hematocrit; videomicroscopic image of sublingual microcirculation) will be recorded in pre-determined time points during the first 72 in-hospital hours. The relation between exhaled methane levels and indicators of shock will constitute our primary outcome measures. The association of methane concentrations with clinical outcomes (transfusion need, mortality) will serve as secondary outcomes.

Being tested
Measurement of methane concentrations in exhaled breath, Videomicroscopy of the sublingual microcirculation, Blood gas and laboratory analysis, Hemodynamic monitoring
Keywords
shock, hemorrhagic, methane
Medical subject headings
Shock, Hemorrhagic, Wounds and Injuries, Shock

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Measurement of methane concentrations in exhaled breathDiagnostic test

    To measure methane concentrations, a near-infrared laser technique-based photoacoustic apparatus will be attached to the exhalation outlet of the ventilator upon arrival of severely injured patients. Exhaled methane levels will be monitored continuously during the first 72 in-hospital hours and will be recorded at pre-determined time points (directly upon arrival, 6 hours post-admission, 12 hours post-admission, 24 hours post-admission, 48 hours post-admission and 72 hours post-admission).

  • Videomicroscopy of the sublingual microcirculationDiagnostic test

    Also called Videomicroscopy using orthogonal polarization spectral imaging (Cytoscan A/R Cytometrics)

    Orthogonal polarization spectral imaging technique (Cytoscan A/R, Cytometrics) will be used to visualize the microcirculation of the sublingual mucosa of the patients. The OPS technique utilizes reflected, polarized light at the wavelength of the isobestic point of oxyhemoglobin and deoxyhemoglobin (548 nm). The diminution of sublingual microcirculation can refer to circulatory redistribution due to hemorrhage. Sublingual microcirculation of the patients will be visualized and evaluated at pre-determined time points (directly upon arrival, 6 hours post-admission, 12 hours post-admission, 24 hours post-admission, 48 hours post-admission and 72 hours post-admission) during the first 72 in-hospital hours.

  • Blood gas and laboratory analysisDiagnostic test

    Arterial blood gas analysis and laboratory testing of venous blood are routine examinations in clinical practice. Base deficit and lactate are considered as global markers of blood loss and shock, and can be obtained rapidly with blood gas analysis. Hemoglobin and hematocrit values can correspond to the severity of blood loss, and are measured routinely both from arterial and venous blood. Sampling of arterial and venous blood for blood gas and laboratory analyses will be performed at pre-determined time points (directly upon arrival, 24 hours post-admission, 48 hours post-admission and 72 hours post-admission) during the first 72 in-hospital hours.

  • Hemodynamic monitoringDiagnostic test

    Also called Monitoring vital signs

    Hemodynamic monitoring is an essential part of emergency trauma care. Non-invasive monitoring of blood pressure, heart rate and respiratory rate of patients will be started immediately upon arrival. After patients are stabilized, invasive arterial blood pressure (IABP) monitoring can be started. IABP is considered as the gold standard of blood pressure measurement in critical care as it reflects the fluctuations of blood pressure in real time. Blood pressure and heart rate values will be recorded at pre-determined time points (directly upon arrival, 6 hours post-admission, 12 hours post-admission, 24 hours post-admission, 48 hours post-admission and 72 hours post-admission) during the first 72 in-hospital hours.

Study groups in NCT04987411
Study groupRoleWhat they receive
Hemorrhagic groupPatients with bleeding confirmed with eFAST or CT.
Receives: Diagnostic Test: Measurement of methane concentrations in exhaled breath; Diagnostic Test: Videomicroscopy of the sublingual microcirculation; Diagnostic Test: Blood gas and laboratory analysis; Diagnostic Test: Hemodynamic monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association between exhaled methane levels and vital signs

    We intend to investigate the relation between exhaled methane levels and systolic blood pressure and heart rate.

    Measured: First 72 in-hospital hours

  2. Association between exhaled methane levels and blood gas and laboratory markers

    We intend to investigate the relation between exhaled methane levels and blood gas and laboratory markers (base deficit, lactate, hemoglobin, hematocrit).

    Measured: First 72 in-hospital hours

  3. Association between exhaled methane levels and sublingual microcirculation

    We intend to investigate the relation between exhaled methane concentrations and sublingual microcirculation.

    Measured: First 72 in-hospital hours

Secondary outcomes (2)
  1. Association between exhaled methane levels and mortality

    The relation between exhaled methane levels and mortality will be assessed.

    Measured: First 72 in-hospital hours

  2. Association between exhaled methane levels and number of packed red blood cells required for transfusion/massive transfusion

    The relation between exhaled methane levels and the number of packed red blood cells required for transfusion/massive transfusion will be assessed.

    Measured: First 72 in-hospital hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2021
  2. Study start1 Nov 2021 (estimated)
  3. Primary completion1 Nov 2022 (estimated)
  4. Study completion31 Jan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04987411
Sponsor's protocol ID
5400/2021-SZTE
Status last verified
Sep 2021
First submitted
27 Jul 2021
Last updated
28 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Barsony A, Vida N, Gajda A, Rutai A, Mohacsi A, Szabo A, Boros M, Varga G, Erces D. Methane Exhalation Can Monitor the Microcirculatory Changes of the Intestinal Mucosa in a Large Animal Model of Hemorrhage and Fluid Resuscitation. Front Med (Lausanne). 2020 Oct 22;7:567260. doi: 10.3389/fmed.2020.567260. eCollection 2020.

    PubMed 33195312
  • Szucs S, Bari G, Ugocsai M, Lashkarivand RA, Lajko N, Mohacsi A, Szabo A, Kaszaki J, Boros M, Erces D, Varga G. Detection of Intestinal Tissue Perfusion by Real-Time Breath Methane Analysis in Rat and Pig Models of Mesenteric Circulatory Distress. Crit Care Med. 2019 May;47(5):e403-e411. doi: 10.1097/CCM.0000000000003659.

    PubMed 30985462
  • Szabo A, Unterkofler K, Mochalski P, Jandacka M, Ruzsanyi V, Szabo G, Mohacsi A, Teschl S, Teschl G, King J. Modeling of breath methane concentration profiles during exercise on an ergometer. J Breath Res. 2016 Feb 1;10(1):017105. doi: 10.1088/1752-7155/10/1/017105.

    PubMed 26828421
  • Javor P, Rarosi F, Horvath T, Torok L, Varga E, Hartmann P. Detection of exhaled methane levels for monitoring trauma-related haemorrhage following blunt trauma: study protocol for a prospective observational study. BMJ Open. 2022 Jul 6;12(7):e057872. doi: 10.1136/bmjopen-2021-057872.

    PubMed 35793921

Questions about this trial

What is this clinical trial studying?

An observational study of Hemorrhagic Shock and Trauma, run by Szeged University at 1 site in Hungary.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hungary. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Petra Dr. Hartmann, MD, Ph.D. (+3662545531 ext. +36304388695, hatmann.petra@med.u-szeged.hu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association between exhaled methane levels and vital signs (time frame: First 72 in-hospital hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04987411, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in